Sequenta Expands Sample Types Accepted for ClonoSIGHT MRD Test for Leukemia, Lymphoma
Ultra-sensitive detection of minimal residual disease now available to more people with blood cancers.
Read More
Search Results for: leukemia
Personalized Medicine: Keeping Up with Change
Reimbursement looms as major challenge
Read More
Sequenta Introduces ClonoSIGHT, Sequencing-Based MRD Test for Leukemia, Lymphoma
The test has been shown to offer sensitivity for the detection of residual cancer cells in marrow or blood.
Read More
Emerging Technologies: NGS Gains Foothold
As the potential use and benefit of next-gen sequencing becomes more evident, the arrival of this emerging technology and the resulting paradigm shift seem imminent.
Read More
Trovagene Grants License for Marker for AML to Duke
Clinical labs have been interested in licensing the assay so they can offer it to physicians for use in patient care.
Read More